{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:32:28Z","timestamp":1782124348702,"version":"3.54.5"},"reference-count":56,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Latvian Council of Science","award":["r.lzp-2020\/1\u20130269"],"award-info":[{"award-number":["r.lzp-2020\/1\u20130269"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Some studies have found increased coronavirus disease-19 (COVID-19)-related morbidity and mortality in patients with primary antibody deficiencies. Immunization against COVID-19 may, therefore, be particularly important in these patients. However, the durability of the immune response remains unclear in such patients. In this study, we evaluated the cellular and humoral response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigens in a cross-sectional study of 32 patients with primary antibody deficiency (n = 17 with common variable immunodeficiency (CVID) and n = 15 with selective IgA deficiency) and 15 healthy controls. Serological and cellular responses were determined using enzyme-linked immunosorbent assay and interferon-gamma release assays. The subsets of B and T lymphocytes were measured using flow cytometry. Of the 32 patients, 28 had completed the vaccination regimen with a median time after vaccination of 173 days (IQR = 142): 27 patients showed a positive spike-peptide-specific antibody response, and 26 patients showed a positive spike-peptide-specific T-cell response. The median level of antibody response in CVID patients (5.47 ratio (IQR = 4.08)) was lower compared to healthy controls (9.43 ratio (IQR = 2.13)). No difference in anti-spike T-cell response was found between the groups. The results of this study indicate that markers of the sustained SARS-CoV-2 spike-specific immune response are detectable several months after vaccination in patients with primary antibody deficiencies comparable to controls.<\/jats:p>","DOI":"10.3390\/vaccines11020354","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T05:09:20Z","timestamp":1675400960000},"page":"354","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-2037","authenticated-orcid":false,"given":"Zane","family":"Lucane","sequence":"first","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiba","family":"Slisere","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"},{"name":"Pauls Stradins Clinical University Hospital, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lota","family":"Ozola","sequence":"additional","affiliation":[{"name":"Children\u2019s Clinical University Hospital, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrijs","family":"Rots","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"},{"name":"Children\u2019s Clinical University Hospital, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindija","family":"Papirte","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-7067","authenticated-orcid":false,"given":"Baiba","family":"Vilne","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7219-1294","authenticated-orcid":false,"given":"Linda","family":"Gailite","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalja","family":"Kurjane","sequence":"additional","affiliation":[{"name":"Riga Stradins University, Riga LV-1007, Latvia"},{"name":"Pauls Stradins Clinical University Hospital, Riga LV-1007, Latvia"},{"name":"Children\u2019s Clinical University Hospital, Riga LV-1007, Latvia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"ref_1","unstructured":"Gathmann, B., Grimbacher, B., Beaut\u00e9, J., Dudoit, Y., Mahlaoui, N., Fischer, A., Knerr, V., Kindle, G., Micol, R., and Benslama, L. (2009). Proceedings of the Clinical and Experimental Immunology, Oxford University Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/sji.12499","article-title":"Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management","volume":"85","author":"Yazdani","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.3389\/fimmu.2019.02593","article-title":"Predominantly Antibody-Deficient Patients With Non-Infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells","volume":"10","author":"Edwards","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and the Miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jinf.2020.05.017","article-title":"Impacts of Immunosuppression and Immunodeficiency on COVID-19: A Systematic Review and Meta-Analysis","volume":"81","author":"Gao","year":"2020","journal-title":"J. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13073-022-01100-3","article-title":"Clinical Implications of Host Genetic Variation and Susceptibility to Severe or Critical COVID-19","volume":"14","author":"Netea","year":"2022","journal-title":"Genome Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1089\/jir.2020.0210","article-title":"Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review","volume":"40","author":"Liu","year":"2020","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1016\/j.jaip.2021.04.017","article-title":"Clinical Outcome, Incidence, and SARS-CoV-2 Infection-Fatality Rates in Italian Patients with Inborn Errors of Immunity","volume":"9","author":"Milito","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MOP.0000000000001062","article-title":"Coronavirus Disease 2019 in Patients with Inborn Errors of Immunity: Lessons Learned","volume":"33","author":"Bucciol","year":"2021","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"994253","DOI":"10.3389\/fimmu.2022.994253","article-title":"Outcome of SARS-CoV-2 Infection among Patients with Common Variable Immunodeficiency and a Matched Control Group: A Danish Nationwide Cohort Study","volume":"13","author":"Katzenstein","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/ACI.0000000000000786","article-title":"Mechanisms Underlying Host Defense and Disease Pathology in Response to Severe Acute Respiratory Syndrome (SARS)-CoV2 Infection: Insights from Inborn Errors of Immunity","volume":"21","author":"Tangye","year":"2021","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in Patients with Primary and Secondary Immunodeficiency: The United Kingdom Experience","volume":"147","author":"Shields","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s10875-021-01066-8","article-title":"Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study","volume":"41","author":"Goudouris","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_15","first-page":"5656","article-title":"COVID-19 in Unvaccinated Patients with Inborn Errors of Immunity\u2014Polish Experience","volume":"13","author":"Becht","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7883\/yoken.JJID.2021.281","article-title":"Relationship between Selective IgA Deficiency and COVID-19 Prognosis","volume":"75","author":"Kandemir","year":"2022","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3164\/jcbn.20-102","article-title":"Association between Selective IgA Deficiency and COVID-19","volume":"67","author":"Naito","year":"2020","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_18","unstructured":"(2022, October 25). ESID-European Society for Immunodeficiencies. Available online: https:\/\/esid.org\/COVID-19\/ESID-COVID-19-Statement-March-2022."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of MRNA-1273 Vaccine\u2013Induced Antibodies against SARS-CoV-2 Variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Post, N., Eddy, D., Huntley, C., van Schalkwyk, M.C.I., Shrotri, M., Leeman, D., Rigby, S., Williams, S.V., Bermingham, W.H., and Kellam, P. (2020). Antibody Response to SARS-CoV-2 Infection in Humans: A Systematic Review. PLoS ONE, 15.","DOI":"10.1101\/2020.08.25.20178806"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJMc2032195","article-title":"Durability of Responses after SARS-CoV-2 MRNA-1273 Vaccination","volume":"384","author":"Widge","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and Immunological Assessment of Asymptomatic SARS-CoV-2 Infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of Antibody Immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3389\/fimmu.2022.912571","article-title":"Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study","volume":"13","author":"Shields","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaci.2021.11.022","article-title":"Immunogenicity and Tolerability of COVID-19 Messenger RNA Vaccines in Primary Immunodeficiency Patients with Functional B-Cell Defects","volume":"149","author":"Pham","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10875-022-01231-7","article-title":"SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deciency: Findings From The COV-AD Study upon Tyne Hospitals NHS Foundation Trust Teaching Hospitals NHS Trust","volume":"42","author":"Shields","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"603972","DOI":"10.3389\/fimmu.2020.603972","article-title":"Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools","volume":"11","author":"Lecrevisse","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"727850","DOI":"10.3389\/fimmu.2021.727850","article-title":"Humoral and Cellular Response Following Vaccination With the BNT162b2 MRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies","volume":"12","author":"Amodio","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 Vaccine Induces Neutralizing Antibodies and Poly-Specific T Cells in Humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early Induction of Functional SARS-CoV-2-Specific T Cells Associates with Rapid Viral Clearance and Mild Disease in COVID-19 Patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive Immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-Specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls","volume":"584","author":"Tan","year":"2020","journal-title":"Nature"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 Vaccine in Patients with Inborn Errors of Immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s10875-021-01133-0","article-title":"SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does Their Best","volume":"41","author":"Salinas","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jaci.2021.08.016","article-title":"Antibody Responses to the SARS-CoV-2 Vaccine in Individuals with Various Inborn Errors of Immunity","volume":"148","author":"Delmonte","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10875-022-01296-4","article-title":"Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 MRNA Vaccines in Patients with Primary Antibody Deficiency","volume":"42","author":"Shin","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1016\/j.jaip.2021.06.019","article-title":"Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19","volume":"9","author":"Ameratunga","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"Personal View A Minimal Common Outcome Measure Set for COVID-19 Clinical Research","volume":"20","author":"Marshall","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115573","DOI":"10.1016\/j.diagmicrobio.2021.115573","article-title":"Commercial Interferon-Gamma Release Assay to Assess the Immune Response to First and Second Doses of MRNA Vaccine in Previously COVID-19 Infected versus Uninfected Individuals","volume":"102","author":"Tormo","year":"2022","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common Variable Immunodeficiency Disorders: Division into Distinct Clinical Phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2018.02130","article-title":"Assessing Disease Severity in Common Variable Immunodeficiency Disorders (CVID) and CVID-Like Disorders","volume":"9","author":"Ameratunga","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1025373601374","article-title":"Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects","volume":"23","author":"Piqueras","year":"2003","journal-title":"J. Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe Deficiency of Switched Memory B Cells (CD27(+)IgM(-)IgD(-)) in Subgroups of Patients with Common Variable Immunodeficiency: A New Approach to Classify a Heterogeneous Disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass Trial: Defining Subgroups in Common Variable Immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1182\/blood-2011-06-361881","article-title":"B-Cell Replication History and Somatic Hypermutation Status Identify Distinct Pathophysiologic Backgrounds in Common Variable Immunodeficiency","volume":"118","author":"Driessen","year":"2011","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s10875-022-01229-1","article-title":"Inborn Errors of Immunity in Latvia: Analysis of Data from 1994 to 2020","volume":"42","author":"Prokofjeva","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"103705","DOI":"10.1016\/j.ebiom.2021.103705","article-title":"Safety and Efficacy of the MRNA BNT162b2 Vaccine against SARS-CoV-2 in Five Groups of Immunocompromised Patients and Healthy Controls in a Prospective Open-Label Clinical Trial","volume":"74","author":"Bergman","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.anai.2021.05.015","article-title":"Seroconversion after Coronavirus Disease 2019 Vaccination in Patients with Immune Deficiency","volume":"127","author":"Squire","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.amjms.2020.07.027","article-title":"Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor?","volume":"360","author":"Babaha","year":"2020","journal-title":"Am. J. Med. Sci."},{"key":"ref_50","first-page":"5063","article-title":"Reactogenicity and Immunogenicity of the Second COVID-19 Vaccination in Patients with Inborn Errors of Immunity or Mannan-Binding Lectin Deficiency","volume":"13","author":"Mrak","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"MRNA Vaccines\u2014A New Era in Vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.jaip.2020.04.019","article-title":"Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency","volume":"8","author":"Friedmann","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","article-title":"Immunological Memory to SARS-CoV-2 Assessed for up to 8 Months after Infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the Elderly: The Challenge of Immune Changes with Aging","volume":"40","author":"Ciabattini","year":"2018","journal-title":"Semin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jaci.2018.02.052","article-title":"Predictive Markers for Humoral Influenza Vaccine Response in Patients with Common Variable Immunodeficiency","volume":"142","author":"Gardulf","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/infdis\/jis487","article-title":"Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis by Etiology","volume":"206","author":"Beck","year":"2012","journal-title":"J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/354\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:23:23Z","timestamp":1760120603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["vaccines11020354"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11020354","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}